Company intelligence / Profile preview

Salvia Scientific

Undisclosed, Netherlandspmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Salvia BioElectronics is developing implantable bioelectronic systems for neurostimulation therapy, focusing on chronic migraine and neuropathic pain. SALVIA MEDICAL SCIENCES LTD publishes learned journals and is involved in human health activities. Salvia GmbH is a German VC firm investing in deep-tech/science startups.

Therapeutic areas: Neurology
Modalities: Neurostimulation devices
Industry: Implantable Medical Devices

Drug pipeline

1 asset

salvia miltiorrhiza injection

Pre-clinical

Indications: Acute lung injury

Beyond the preview

Go deeper on Salvia Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salvia Scientific.

Explore the full profile